Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will present new data on minimal residual disease (MRD) negativity rates from the Phase 3 CARTITUDE-4 trial ...

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic ...

of 6-mercaptopurine per day ... cell leukemia, with myeloid characteristics as shown, for example, by a positive peroxidase reaction. Leukemias of this kind, even a few years ago, ran an acute ...

Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Treatment with Scemblix was shown to improve response rates in patients with newly diagnosed Philadelphia chromosome-positive ...

"Who's afraid of little ol' me? Cancer should be," Everson said. In April, this IU senior was diagnosed with acute myeloid leukemia, right after she bought tickets for the Eras Tour at Lucas Oil ...

Chronic myeloid leukemia (CML) is a rare type of cancer that forms in the bone marrow before spilling into the blood. It is a slow-growing type of leukemia that can turn acute if not treated ...

Former Hollywood producer Harvey Weinstein has chronic myeloid leukemia (CML), NBC News reported ... Court of Appeals threw out the conviction in April, finding Weinstein did not get a fair ...